3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Carcinosarcoma
1
Endometrial Neoplasms
1
Cystadenocarcinoma, Serous
1
Interventions
trametinib
1
niraparib
1
liposomal doxorubicin
1
Topotecan
1
Taxes
1
Tamoxifen
1
Paclitaxel
1
Letrozole
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Cystadenocarcinoma, Serous
×
niraparib
×
Clear all
NCT04159155
2025-08-12
CAN-STAMP
University Health Network, Toronto
Phase 2/3
Terminated
11 enrolled